The UK must establish new regulations for AI technologies utilized in the NHS and other healthcare environments, according to the nation’s regulatory authority.
The Medicines and Healthcare Products Regulatory Agency (MHRA), responsible for overseeing medical devices and approving pharmaceuticals in the UK, has released a comprehensive report featuring 44 recommendations aimed at updating its regulatory framework to accommodate the increasing use of AI in healthcare.
In a statement to the BBC, MHRA chief Lawrence Tallon indicated that AI technology will soon become a standard component of NHS services.
“Patients will… increasingly see AI as part of the way that normal NHS healthcare is delivered,” he remarked, emphasizing the need for trust and confidence among patients regarding these advancements.
The report’s findings are the result of contributions from over 12,000 individuals, including both patients and healthcare professionals.
Key recommendations from the report include:
-
Ongoing evaluation of AI products, with the authority to revoke regulatory approval if performance deteriorates or malfunction occurs.
-
Ensuring patients are informed about the involvement of AI in their treatment, along with easy access to detailed information about these technologies.
-
Empowering regulators to impose penalties on AI developers who fail to adhere to necessary standards.
-
Introducing an AI “L plate” system to facilitate the trial of new AI models by healthcare professionals under strict supervision.
Tallon remarked that the existing medical device regulation largely stems from a time when the focus was on conventional products like hip and knee replacements, or simpler items like stethoscopes and bandages.
While current regulations may suffice for basic AI applications, such as those designed to detect known symptoms in imaging scans, they do not adequately address more sophisticated models.
“These products evolve even after they’ve been authorized,” Tallon elaborated. “As new data is introduced, they learn and adapt.”
He also acknowledged that regulating AI is a challenge faced globally, stating, “At this moment, we cannot point to a country or regulatory framework that has completely solved this issue.”
Editor’s Take
This development underscores the pressing need for regulations that can keep pace with the rapid evolution of AI in healthcare. By establishing clear guidelines, the MHRA aims to build trust with patients, ensuring that AI technologies enhance rather than compromise the quality of care. As the AI landscape continues to expand, these regulatory frameworks could prove essential for developers and businesses operating within the healthcare sector.
Source: www.bbc.co.uk
